Department of Hepatology and Gastroenterology, The Second Part of First Hospital, Jilin University, Changchun 130021, Jilin Province, China; Department of Central Laboratory, The First Hospital, Jilin University, Changchun 130021, Jilin Province, China.
Intensive Care Unit, The First Hospital, Jilin University, Changchun 130021, Jilin Province, China.
Int Immunopharmacol. 2018 Apr;57:181-189. doi: 10.1016/j.intimp.2018.02.018. Epub 2018 Mar 5.
Despite the role of monocytes in the pathogenesis of severe acute pancreatitis (SAP), it remains unclear how different subtypes of monocytes regulate and contribute to this pathogenesis.
We examined the numbers of different subsets of monocytes by flow cytometry in 21 SAP, 15 mild acute pancreatitis (MAP) and 13 healthy controls (HC). The concentrations of plasma cytokines were assessed by cytometric bead array. Disease severity was evaluated based on the acute physiology and chronic health evaluation (APACHE) II score and plasma C-reactive proteins (CRP) levels.
Compared with the numbers in MAP patients and HC, we observed that the numbers of CD14CD163, CD14CD163MAC387, CD14CD163IL-12 M1 monocytes, and CD115, CD204, IL-10 M2 monocytes were significantly increased in SAP patients. In addition, these patients showed higher plasma levels of interleukin (IL)-12 and IL-10. Furthermore, the number of CD14CD163, CD14CD163MAC387 M1 monocytes and the plasma IL-12 concentration showed a positive association with the CRP level, while the number of CD204, IL-10 M2 monocytes and the plasma IL-10 concentration showed a positive correlation with the APACHE II score. Importantly, the CD115 M2 subset displayed a positive correlation with both the CRP level and APACHE II score, and treatment of SAP significantly reduced the number of this subset.
The CD14CD163CD115 M2 monocyte count appears to be important factor in determining the severity and prognosis of SAP. Both the pro- and anti-inflammatory monocytes appear to participate in the pathogenesis of SAP.
尽管单核细胞在重症急性胰腺炎(SAP)的发病机制中起作用,但单核细胞的不同亚型如何调节和促成这一发病机制仍不清楚。
我们通过流式细胞术检查了 21 例 SAP、15 例轻症急性胰腺炎(MAP)和 13 例健康对照(HC)患者不同亚群单核细胞的数量。通过细胞因子检测微珠阵列评估血浆细胞因子浓度。根据急性生理学和慢性健康评估(APACHE)II 评分和血浆 C 反应蛋白(CRP)水平评估疾病严重程度。
与 MAP 患者和 HC 相比,我们观察到 SAP 患者的 CD14CD163、CD14CD163MAC387、CD14CD163IL-12 M1 单核细胞和 CD115、CD204、IL-10 M2 单核细胞数量显著增加。此外,这些患者的血浆白细胞介素(IL)-12 和 IL-10 水平较高。此外,CD14CD163、CD14CD163MAC387 M1 单核细胞数量和血浆 IL-12 浓度与 CRP 水平呈正相关,而 CD204、IL-10 M2 单核细胞数量和血浆 IL-10 浓度与 APACHE II 评分呈正相关。重要的是,CD115 M2 亚群与 CRP 水平和 APACHE II 评分均呈正相关,SAP 的治疗显著降低了该亚群的数量。
CD14CD163CD115 M2 单核细胞计数似乎是决定 SAP 严重程度和预后的重要因素。促炎和抗炎单核细胞似乎都参与了 SAP 的发病机制。